About

BAM15 is a novel, orally bioavailable mitochondrial uncoupler. It increases energy expenditure and supports fat loss without affecting appetite, core body temperature, or muscle mass.

Mechanism of Action

BAM15 makes mitochondria less efficient by 'uncoupling' the process of fuel burning from energy (ATP) production. This inefficiency forces the mitochondria to burn more fuel (like fat) to produce the same amount of ATP, thereby increasing overall metabolic rate.

Key Benefits

• Increases energy expenditure
• Promotes fat loss without affecting appetite
• Improves insulin sensitivity
• Protects against cellular damage from oxidative stress

Clinical Research

In preclinical studies, BAM15 has been shown to reduce fat mass, improve insulin sensitivity, and protect from diet-induced obesity in animal models, all without the side effects associated with older uncoupling agents.

Potential Side Effects

Unlike older mitochondrial uncouplers (like DNP), BAM15 has not been found to significantly increase core body temperature, making it a much safer compound for research.

Usage & Dosage

As an orally bioavailable capsule, it is administered orally. Research is ongoing to determine optimal human equivalent dosages and protocols.

Peptide Storage

References

• BAM15 is a mitochondrial uncoupler that reduces body weight and improves glucose tolerance in mice